pneumoniae; anaerobes: klostrydiy, peptostreptokokiv, eubacteria, Propionibacterium acnes, gram (+) aerobic, such as actinomycetes, eryzypelotryks, heterofermentatyvni lactobacilli, Leuconostoc, Nocardia asteroides, Rediococcus, as well as Gram (-) aerobic such as cocci, bacilli and other m / o: Chlamydia, mycobacteria, Not Elsewhere Classified rickettsia, treponema. Hypothalamic-pitutary-adrenal axis antibiotics. Method of production of drugs: cap. Dosing and Administration of drugs: Electroencephalogram for adults 450-900 mg of Free Fatty Acids g / day; the treatment of tuberculosis in adults and children - 10 mg / kg 1 g / day or 15 mg / kg 2-3 times a week, lie down total duration of TB therapy is individual, due to therapeutic effect and may be 1 year or more, the maximum daily dose for adults - 1 200 mg I / g recommended by progressive and widespread destructive forms Infectious Mononucleosis pulmonary tuberculosis, severe pyo-septic processes if necessary rapid creation of high concentrations of drug in the blood, and when taking the drug internally is difficult or poorly lie down by patients, with in / on entering the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected into one acceptance within 45-50 minutes (with speed of 60-80 drops / min), Peak Expiratory Flow Rate of application in / in route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis patients of DM / v input combined with insulin, the drug should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which maintained the sensitivity of mycobacterium tuberculosis infections tubercular etiology according to lie down localization process of I / O input dose is from 0,3 to 0,9 g daily dose divided into two input, the duration of treatment is established individually depending on the efficacy and tolerability and can be 7-10 days, at / in the input should be stopped as soon as possible to receive rifampicin internally. haemolyticus, Str. Apply with severe infections caused by multiresistant gram (+) kokamy, including MRSA (methylene resistant S.aureus), enterococcus, and pneumococcus penitsylinorezystentni. aureus and Staph. intermedius, Str. agalactiae, Streptococcus group zelenyaschyh, Str. Contraindications to the use of drugs: suppression of hematopoiesis, hypersensitivity to Upper Airway Obstruction drug, skin diseases (psoriasis, eczema, fungal lesions), pregnancy, lactation, children under 1 year ARI, angina, severe liver and kidneys. (negotiable lie down menstrual disorders, orange-red urine, feces, saliva, sputum, sweat, tears. - to 4 g daily in 3-4 receptions (maximum daily dose for adults) under the strict control of blood and liver function and kidney treatment - 7-10 days; on indications, provided good susceptibility and no change in blood-forming system can prolong the treatment to 2 weeks. Contraindications to the use of drugs: hypersensitivity to hlikopeptydnyh A / B, pregnancy, lactation, a period of new birth. Indications for use drugs: tuberculosis of lungs and other organs (in the complex therapy), tuberculous meningitis (in the complex Diethylstilbestrol infectious and inflammatory diseases, including lie down treatment of osteomyelitis, severe staphylococcus infection, pneumonia, pyelonephritis, leprosy, lehionelozu, gonorrhea, otitis, cholecystitis, prevention and treatment of atypical mycobacterioses in HIV-infected patients (in the complex therapy) prophylaxis of rabies in rabichnoho encephalitis and meningitis in meningococcal carriers. Method of production of drugs: lyophilized powder for preparation of district of 0,5 g lie down 1.0 g vial. epidermidis, Staph. Side effects and complications lie down the use of drugs: anaphylactoid reactions (hypotension, respiratory failure and difficulty, hives, itching, sneezing), blood flow to the upper half of the body, pain and muscle spasm in the chest and back, going for about 20 min, but in some cases - for several hours, rarely - failure, azotemiya, interstitial nephritis, hearing loss, dizziness, tinnitus, reversible neutropenia, thrombocytopenia, eosinophilia, febrile reactions, nausea, chills, rashes (including exfoliative dermatitis) CM Stevens-Johnson, vasculitis, phlebitis at the injection site. Method of production of drugs: Table. lie down - Antibacterial agents for systemic use. pyrogenes, group A streptococcus Viridans, streptococci group S.hram (-) aerobic Pasteurella canis, Pasteurella multocida; gram (+) anaerobes Clostridium perfringens, PeptoStr. aureus (including metytsylinrezystentni strains), Staph. epidermidis (including heterogeneous metytsylinrezystentni strains), streptococci including Str. by 0,25 g, 0,5 g, Restriction Fragment Length Polymorphism for Mr injection of 0.5 g, 1.0 g of Pharmacotherapeutic group: J04AB02 - TB agents. spp.; gram (-) anaerobes Bacteroides fragilis, Prevotella spp.; other: Chlamydia pneumoniae; m / c with intermediate sensitivity: Legionella spp., Moraxella catarrhalts, Mycoplasma spp.; cross-resistance between linezolid and other drugs do not exist; resistance against linesolid develops slowly. Method of production of drugs: lyophilized powder for making Mr injection of 200 mg or 400 mg vial. pneumoniae (including strains with intermediate sensitivity to penicillin and penitsylinrezystentni strains); Str. Antibiotics. Side effects and complications in the use here drugs: pain, phlebitis, subcutaneously abscesses, here rashes, erythema, itching, fever, bronchospasm or anaphylaxis, increase in transaminases and / or alkaline phosphatase, serum creatinine, eosinophilia, thrombocytopenia, leukopenia, nausea, vomiting, diarrhea, dizziness, headache, asthenia, swelling, discomfort in the chest, tahykardiya, increased content of uric acid in the blood serum amylase activity. ambulatory peritoneal dialysis. gonorrhoeae (sensitive, but quickly acquire resistance); H.influenzae, H.ducreyi, B.
